Discontinued — last reported Q3 '23
Union Pacific Interest Paid increased by 93.4% to $441.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.5%, from $439.00M to $441.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 4.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $141.00M | $369.00M | $183.00M | $382.00M | $183.00M | $415.00M | $176.00M | $454.00M | $174.00M | $485.00M | $155.00M | $463.00M | $172.00M | $439.00M | $186.00M | $439.00M | $171.00M | $473.00M | $228.00M | $441.00M |
| QoQ Change | — | +161.7% | -50.4% | +108.7% | -52.1% | +126.8% | -57.6% | +158.0% | -61.7% | +178.7% | -68.0% | +198.7% | -62.9% | +155.2% | -57.6% | +136.0% | -61.0% | +176.6% | -51.8% | +93.4% |
| YoY Change | — | — | — | — | +29.8% | +12.5% | -3.8% | +18.8% | -4.9% | +16.9% | -11.9% | +2.0% | -1.1% | -9.5% | +20.0% | -5.2% | -0.6% | +7.7% | +22.6% | +0.5% |
We use cookies for analytics. See our Privacy and Cookie Policy.